Service profile
NervGen Pharma
Clinical-stage biopharmaceutical company developing NVG-291, a therapeutic targeting nervous system repair for spinal cord injury, multiple sclerosis, Alzheimer's disease, and other neurological conditions.
About
What NervGen Pharma is
Clinical-stage biopharmaceutical company developing NVG-291, a therapeutic targeting nervous system repair for spinal cord injury, multiple sclerosis, Alzheimer's disease, and other neurological conditions.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://nervgenpharma.com |
| Status coverage | Public status page |
| Founded | 2010 |
| Headquarters | Vancouver, British Columbia, Canada |
| Categories | Enterprise, Healthcare |
Loading offerings...